• Explore /
  • Poster
  • / EPAZ: A randomized phase II trial comparing pazopanib with doxorubicin as first line treatment in elderly patients with metastatic or advanced soft tissue sarcoma of the Working Group Medical Oncology (AIO) and German Interdisciplinary Sarcoma Group (GISG).

EPAZ: A randomized phase II trial comparing pazopanib with doxorubicin as first line treatment in elderly patients with metastatic or advanced soft tissue sarcoma of the Working Group Medical Oncology (AIO) and German Interdisciplinary Sarcoma Group (GISG).

Abstract Poster

Authors

Viktor Grünwald

Viktor Gruenwald

Medical School of Hannover, Hannover, Germany

Viktor Gruenwald , Annegret Kunitz , Markus Kajo Schuler , Hans-Georg Kopp , Bernd Kasper , Lars Lindner , Jens-Marcus Chemnitz , Alexander Stein , Patrick Schöffski , Bjoern Steffen , Sebastian Bauer , Gerlinde Egerer , Michael Kneba , Martina Crysandt , Armin Koch

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT01861951

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS10576)

DOI

10.1200/jco.2015.33.15_suppl.tps10576

Abstract #

TPS10576

Poster Bd #

219b

Abstract Disclosures

Similar Posters

First Author: Makoto Endo

First Author: Erlinda Maria Gordon

First Author: Viktor Grünwald

First Author: Claudia María Valverde